124 related articles for article (PubMed ID: 32809160)
21. The role of FDG PET-CT in differential diagnosis of pleural pathologies.
Elboga U; Yılmaz M; Uyar M; Zeki Çelen Y; Bakır K; Dikensoy O
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):187-91. PubMed ID: 23067687
[TBL] [Abstract][Full Text] [Related]
22. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
[TBL] [Abstract][Full Text] [Related]
23. Is 18F-FDG PET/CT capable of differential diagnosis from tuberculous pleurisy from malignant mesothelioma?
Özmen Ö; Tatci E; Demiröz ŞM; Tazeler Z; Demirağ F
Nucl Med Commun; 2021 Jun; 42(6):672-677. PubMed ID: 33625184
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Prior JO; Bertagna F; Ceriani L; Giovanella L
Lung Cancer; 2014 Jan; 83(1):1-7. PubMed ID: 24290256
[TBL] [Abstract][Full Text] [Related]
25. Could SUVmax be an auxiliary parameter in the clinical management of pulmonary hydatid disease?
Ozmen O; Tatci E; Uslu Biner I; Findik G; Yilmaz U; Erturk H; Demirag F
Clin Respir J; 2019 Jan; 13(1):58-65. PubMed ID: 30556309
[TBL] [Abstract][Full Text] [Related]
26. Clinical Value of
Chen Z; Jiang S; Li Z; Rao L; Zhang X
Acad Radiol; 2020 Dec; 27(12):1691-1699. PubMed ID: 32063495
[TBL] [Abstract][Full Text] [Related]
27. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
Kitajima K; Doi H; Kuribayashi K
Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of
Altinmakas E; Hobbs BP; Ye H; Grubbs EG; Perrier ND; Prieto VG; Lee JE; Ng CS
Abdom Radiol (NY); 2017 Feb; 42(2):577-584. PubMed ID: 27665482
[TBL] [Abstract][Full Text] [Related]
30. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P
Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955
[TBL] [Abstract][Full Text] [Related]
31. A propensity score-matched comparison of the efficacies of OK-432 and talc slurry for pleurodesis for malignant pleural effusion induced by lung adenocarcinoma.
Nohara K; Takada K; Kojima E; Ninomiya K; Miyamatsu S; Shimizu T; Sakurai T; Mizuno T; Yamashita Y
Respir Investig; 2016 Sep; 54(5):341-6. PubMed ID: 27566382
[TBL] [Abstract][Full Text] [Related]
32. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
33. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
34. Differentiation and diagnosis of benign and malignant testicular lesions using 18F-FDG PET/CT.
Shao D; Gao Q; Tian XW; Wang SY; Liang CH; Wang SX
Eur J Radiol; 2017 Aug; 93():114-120. PubMed ID: 28668404
[TBL] [Abstract][Full Text] [Related]
35. Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography.
Lee JY; Kim YH; Park YJ; Park SB; Chung HW; Zo JI; Shim YM; Lee KS; Choi JY
Cancer Imaging; 2019 Jun; 19(1):40. PubMed ID: 31227017
[TBL] [Abstract][Full Text] [Related]
36. The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.
Loudini N; Glaudemans AWJM; Jutte PC; Yakar D; Kwee TC
Skeletal Radiol; 2020 Sep; 49(9):1387-1395. PubMed ID: 32253470
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Bertagna F; Prior JO; Ceriani L; Giovanella L
Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
[TBL] [Abstract][Full Text] [Related]
38. FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy.
Genestreti G; Moretti A; Piciucchi S; Giovannini N; Galassi R; Scarpi E; Burgio MA; Amadori D; Sanna S; Poletti V; Matteucci F; Gavelli G
J Cancer; 2012; 3():241-5. PubMed ID: 22670158
[TBL] [Abstract][Full Text] [Related]
39. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
40. Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET/CT.
Sena Y; Matsumoto S; Silman C; Otsuka K; Kiyota T
Ann Nucl Med; 2020 Aug; 34(8):538-544. PubMed ID: 32430619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
